Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy
Sang Nam Lee, Seung Mo Jin, Hong Sik Shin, et al.
Accounts of Chemical Research (2020) Vol. 53, Iss. 10, pp. 2081-2093
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Natural killer cells: a promising immunotherapy for cancer
Junfeng Chu, Fengcai Gao, Meimei Yan, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 112
Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy
Jiali Luo, Handong Wang, Zhan Shi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72
A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion
Seung Mo Jin, Yeon Jeong Yoo, Hong Sik Shin, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 4, pp. 390-402
Open Access | Times Cited: 70
Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
Na Fan, Kepan Chen, Rong Zhu, et al.
Science Advances (2022) Vol. 8, Iss. 51
Open Access | Times Cited: 55
Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy
Shuyan Han, Jun Wu
Bioactive Materials (2022) Vol. 17, pp. 300-319
Open Access | Times Cited: 40
Bioorthogonal Activation of TLR7 Agonists Provokes Innate Immunity to Reinforce Aptamer-Based Checkpoint Blockade
Wei Yue, Geng Qin, Zhao Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 6, pp. 5808-5820
Closed Access | Times Cited: 33
Recent advances in sonodynamic therapy by MOFs-based platforms for biomedical applications
Wenbin Hu, Sanying Wang, Chenyi Jiang, et al.
Dyes and Pigments (2023) Vol. 219, pp. 111596-111596
Closed Access | Times Cited: 32
Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems
Sobia Razzaq, Iqra Fatima, Zeinab Moafian, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
Lingling Huang, Xiaoyan Ge, Yang Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1228-1228
Open Access | Times Cited: 34
Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics
Jiayu Wang, Jifa Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6437-6462
Closed Access | Times Cited: 20
Boosting humoral and cellular immunity with enhanced STING activation by hierarchical mesoporous metal-organic framework adjuvants
Chengjie Huang, Xiao Zhi, Tianbao Ye, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 691-706
Closed Access | Times Cited: 7
Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target
Bingqing Shang, Honglei Cui, Ruiyang Xie, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
Yulei Mu, Zhen Zhang, Huiqun Zhou, et al.
Biomaterials Science (2024) Vol. 12, Iss. 16, pp. 4045-4064
Closed Access | Times Cited: 5
In Silico-Guided Discovery of Polysaccharide Derivatives as Adjuvants in Nanoparticle Vaccines for Cancer Immunotherapy
Zhihong Cui, Chenyu Shi, Ran An, et al.
ACS Nano (2025)
Closed Access
Topology‐Oriented Lymph Node Drainage of Dendritic Polymer‐TLR Agonist Conjugates to Enhance Vaccine Immunogenicity
Long Ren, Bing Wang, Di Miao, et al.
Advanced Materials (2025)
Closed Access
Galloylated Toll-Like Receptor 7/8 Agonist Nanovaccine for Enhanced Tumor Antigen Delivery in Personalized Immunotherapy
Mengyao Ma, Ximu Li, Mingyuan Zhong, et al.
ACS Nano (2025)
Closed Access
Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
Run Zheng, Jian Ma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2285-2285
Open Access | Times Cited: 19
Shifting cold to hot tumors by nanoparticle-loaded drugs and products
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
Liposomes as Immunotherapeutic Carriers: A Game-Changer in Cancer Therapy
Sepehr Hoseinzadeh Moghaddam, Abulfazl Vatankhah, Fatemeh Oroojalian, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106847-106847
Closed Access
A DNA-polymer hybrid nanocomplex based bi-adjuvant vaccine for tumor immunotherapy
Feng Li, Xiaohui Ding, Zhaoyue Lv, et al.
Nano Today (2023) Vol. 54, pp. 102061-102061
Closed Access | Times Cited: 10
A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer
Zhuoxin “Zora” Zhou, Yingnan Si, Jiashuai Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 22, pp. 3848-3863
Open Access | Times Cited: 3
Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy
Theivendren Panneerselvam, Selvaraj Kunjiappan, Parasuraman Pavadai, et al.
ACS Measurement Science Au (2024) Vol. 5, Iss. 1, pp. 31-55
Open Access | Times Cited: 3
Self‐Immolated Nanoadjuvant for In Situ Vaccination Immunotherapy of Colorectal Cancer
Weiqi Wang, Qiwen Zhu, Yilan Jin, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 7
Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation
Liuwei Gu, Xiaojie Kong, Mengyan Li, et al.
Chemical Communications (2024) Vol. 60, Iss. 42, pp. 5474-5485
Closed Access | Times Cited: 2
Immunomodulator-Mediated Suppressive Tumor Immune Microenvironment Remodeling Nanoplatform for Enhanced Immuno/Chemo/Photothermal Combination Therapy of Triple Negative Breast Cancer
Anqi Wang, Xinda Yang, Ruihao Li, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 46, pp. 53318-53332
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top